TrimRx's Blog

9 min read

Energy Returns: The Month-by-Month Vitality Timeline

Introduction Energy on a GLP-1 follows a predictable arc: a dip in the first month or two, a return to baseline around month 3,…

10 min read

Energy and Mitochondria Peptide Stack: MOTS-c, SS-31 & NAD+

Introduction An energy and mitochondria peptide stack is a combination of compounds aimed at improving how your cells produce energy, built around mitochondrial peptides…

9 min read

Employer Coverage Trends: Who Added GLP-1 in 2026

Introduction Employer GLP-1 coverage decides the monthly cost question for more Americans than any government program, because most working-age people get insurance through a…

8 min read

Electrolytes on GLP-1: Do You Actually Need Them?

Most people on a GLP-1 do not need an electrolyte supplement, but a meaningful minority do.

9 min read

Ecnoglutide Explained: China’s GLP-1 Entrant Goes Global

Ecnoglutide is one of several GLP-1 drugs emerging from China’s fast-growing obesity pipeline.

9 min read

EAAs vs Whey on GLP-1: Supplement Priority Guide

Introduction For most people on a GLP-1 drug, whey protein beats standalone EAAs as the supplement to prioritize, because whey delivers complete protein that…

9 min read

Essential Amino Acid Timing on OMAD-Like GLP-1 Eating

Introduction When a GLP-1 medication suppresses your appetite hard enough that you naturally eat once a day, amino acid timing stops being a bodybuilding…

11 min read

Dual-Eligible Patients and GLP-1: Medicare-Medicaid Coordination

Dual-eligible patients sit in the most confusing corner of American health coverage, and GLP-1 access shows exactly why.

10 min read

DSIP Side Effects: Complete Safety Profile and What to Watch

Introduction DSIP has a mild reported side effect profile, but the most honest thing to say about it is that the evidence (including for…

Stay on Track

Join our community and receive:
Expert tips on maximizing your GLP-1 treatment.
Exclusive discounts on your next order.
Updates on the latest weight-loss breakthroughs.